(Q44611999)

4 December 2017

Gastric acid-suppressive therapy and community-acquired respiratory infections (English)

1 reference

4 December 2017

Gastric acid‐suppressive therapy and community‐acquired respiratory infections (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

19 March 2024

author name string

Laheij RJ

1

1 reference

4 December 2017

Janssen MJ

3

1 reference

4 December 2017

Jansen JB

4

1 reference

4 December 2017

R. J F. Laheij

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535879

19 March 2024

M. C. Van Ijzendoorn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535879

19 March 2024

M. J R. Janssen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535879

19 March 2024

J. B M J. Jansen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535879

19 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14535879

full work available at URL

19 March 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2003.01744.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535879

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01744.x

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01744.x

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

Alimentary Pharmacology & Therapeutics

19 March 2024

published in

1 reference

4 December 2017

18

1 reference

4 December 2017

847-851

1 reference

4 December 2017

8

1 reference

Detection of type B influenza virus genes from biopsied gastric mucosa

4 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01744.X

Occurrence and significance of gastric colonization during acid-inhibitory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01744.X

Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01744.X

Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01744.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01744.X

Risk factors for esophageal candidiasis

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer

19 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

Gastric bacterial overgrowth accompanies profound acid suppression

19 March 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study

19 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

The effect of omeprazole on human natural killer cell activity

19 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity

19 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

Effect of lansoprazole on human leukocyte function

19 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions.

19 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01744.X

19 March 2024

Identifiers

1 reference

4 December 2017

1 reference